Guokai Feng

Title: Guokai Feng: Innovator in Tumor-Targeting Peptides

Introduction

Guokai Feng is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of cancer research, particularly in the development of tumor-targeting peptides. His innovative work aims to enhance the diagnosis and therapy of tumors, showcasing his dedication to advancing medical science.

Latest Patents

Guokai Feng holds a patent for a tumor-targeting polypeptide and its applications. This patent describes a tumor-targeting peptide that comprises a typical motif with the general formula of: XX(Y/F)(D/E)(D/E)XX. The motif is selectively connected with 1-3 amino acids at the C-terminal and/or N-terminal. The peptide is designed to target tumor vessels and tumor cells effectively, allowing it to penetrate these cells for improved tumor diagnosis and therapy. He has 1 patent to his name.

Career Highlights

Guokai Feng is affiliated with the Sun Yat-sen University Cancer Center, where he conducts his research and development work. His role at this esteemed institution allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in cancer treatment.

Collaborations

Some of his notable coworkers include Musheng Zeng and Xing Zhang. Their collaborative efforts enhance the research environment and foster innovation in cancer therapies.

Conclusion

Guokai Feng's work in developing tumor-targeting peptides represents a significant advancement in cancer research. His contributions are vital for improving diagnostic and therapeutic strategies in oncology.